Company

ZTi Biosciences

ZTi Biosciences develops and manufactures molecular biology reagents and diagnostic kits, including PCR reagents and DNA purification kits.

About

Founded in 2020 in Daejeon, South Korea, ZTi Biosciences is a biotechnology company that develops and manufactures reagents and diagnostic kits for research and clinical use. Products include PCR reagents, DNA purification kits and enzyme solutions, sold mainly to laboratories, healthcare providers and pharmaceutical companies in North America, Europe and parts of Asia. Jaden C. is CEO. In April 2022 the company raised KRW 5,500.000 mn in Series A funding from investors including Kiwoom Investment and Korea Technology Finance Corporation.

3Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in